| HGNC Family | Non-coding RNAs |
| Name | microRNA 2355 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThe MIR2355 family of microRNAs, including both the –5p and –3p variants, has emerged as a critical regulator in diverse biological contexts. In intervertebral disc degeneration, for example, miR‑2355‑5p has been implicated in disease‐relevant pathways (see."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In gastric cancer, the lncRNA TMEM44‑AS1 sponges miR‑2355‑5p, thereby upregulating PPP1R13L and inhibiting the p53 pathway to promote chemoresistance (see."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn several malignancies, MIR2355 exerts critical influences on tumor behavior through its interactions with competing endogenous RNAs. In bladder cancer, miR‑2355‑5p is sequestered by DDX11‑AS1, affecting the expression of the oncogene LAMB3 and consequently promoting tumorigenesis (see."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " In esophageal squamous cell carcinoma, downregulation of the lncRNA WDFY3‑AS2 releases miR‑2355‑5p, which then downregulates SOCS2 and modulates JAK2/Stat5 signaling to enhance cell proliferation and invasion (see."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " In hepatocellular carcinoma, miR‑2355‑5p has been identified as a candidate regulator targeting PYCR1, implicating it in tumor growth, invasion, and epithelial–mesenchymal transition (see."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Moreover, in erythropoiesis, miR‑2355‑5p overexpression suppresses KLF6 to enhance γ‑globin synthesis, suggesting a role in hematologic regulation (see."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFurthermore, the MIR2355 family is also involved in lung cancers. In lung adenocarcinoma, elevated levels of the miR‑2355‑3p isoform correlate with poor patient prognosis and its inhibition reduces proliferation, migration, and invasion via direct targeting of ZCCHC14 (see."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " In non‑small‑cell lung cancer, a novel circSOD2/miR‑2355‑5p/CAMSAP2 axis has been delineated in which circSOD2 modulates miR‑2355‑5p levels to ultimately influence CAMSAP2 expression, thereby affecting tumor cell growth and epithelial–mesenchymal transition (see."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nCollectively, these studies highlight that MIR2355 functions as a pivotal molecular switch—modulating diverse signaling cascades that govern cell proliferation, apoptosis, epithelial–mesenchymal transition, chemoresistance, and metastasis across a range of pathological conditions. This regulatory versatility positions the MIR2355 family as a promising diagnostic and prognostic biomarker as well as a potential therapeutic target in both cancer and non‐cancer diseases.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Yusong Guo, Lijun Tian, Xing Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ERRFI1 Inhibits Proliferation and Inflammation of Nucleus Pulposus and Is Negatively Regulated by miR-2355-5p in Intervertebral Disc Degeneration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Spine (Phila Pa 1976) (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/BRS.0000000000003011"}], "href": "https://doi.org/10.1097/BRS.0000000000003011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30817728"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30817728"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Mi Zhou, Jiaqi Dong, Junqing Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chitosan-Gelatin-EGCG Nanoparticle-Meditated LncRNA TMEM44-AS1 Silencing to Activate the P53 Signaling Pathway for the Synergistic Reversal of 5-FU Resistance in Gastric Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Adv Sci (Weinh) (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/advs.202105077"}], "href": "https://doi.org/10.1002/advs.202105077"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35717675"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35717675"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Dong Chen, Junyi Chen, Jialin Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "DDX11-AS1"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " Promotes Bladder Cancer Occurrence Via Protecting "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "LAMB3"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " from Downregulation by Sponging "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "miR-2355-5p"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": "."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biother Radiopharm (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/cbr.2019.3021"}], "href": "https://doi.org/10.1089/cbr.2019.3021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32412777"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32412777"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Qing Zhang, Fangxia Guan, Tianli Fan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA WDFY3-AS2 suppresses proliferation and invasion in oesophageal squamous cell carcinoma by regulating miR-2355-5p/SOCS2 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.15488"}], "href": "https://doi.org/10.1111/jcmm.15488"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32536038"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32536038"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Yanzhen Xu, Wenpu Zuo, Xiao Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deciphering the effects of PYCR1 on cell function and its associated mechanism in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biol Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/ijbs.58026"}], "href": "https://doi.org/10.7150/ijbs.58026"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34239351"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34239351"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Yi Cheng, Xuan Shang, Diyu Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-2355-5p regulates γ-globin expression in human erythroid cells by inhibiting KLF6."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Haematol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/bjh.17134"}], "href": "https://doi.org/10.1111/bjh.17134"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33368182"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33368182"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Yanan Zhao, Wenlong Zhang, Yang Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Diagnostic and prognostic value of microRNA-2355-3p and contribution to the progression in lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2021.1952367"}], "href": "https://doi.org/10.1080/21655979.2021.1952367"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34334103"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34334103"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Changsheng Lv, Yiying Hu, Xin Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CircRNA SOD2 motivates non-small cell lungs cancer advancement with EMT via acting as microRNA-2355-5p's competing endogenous RNA to mediate calmodulin regulated spectrin associated proteins-2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2021.2024331"}], "href": "https://doi.org/10.1080/21655979.2021.2024331"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35188072"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35188072"}]}]}]}
|
| Synonyms | MIR-2355 |
| NCBI Gene ID | 100423036 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR2355 has 212 functional associations with biological entities spanning 3 categories (molecular profile, cell line, cell type or tissue, gene, protein or microRNA) extracted from 9 datasets.
Click the + buttons to view associations for MIR2355 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR2355 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR2355 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR2355 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR2355 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of MIR2355 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MIR2355 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR2355 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR2355 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR2355 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |